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Extracellular vesicles (EV) have emerged as important media-
tors of intercellular communication. By their origin, we can find
vesicles derived from plasma membrane such as microvesicles,
ectosomes, and membrane particles or exosomes, which originate
in the endosomal membrane compartment. They contain numer-
ous proteins, lipids, and even nucleic acids like mRNA and miRNA
that can affect the cells that encounter these structures in complex
ways.
The EV have recently gained interest for their therapeutic
potential both as a treatment itself and as a biomarker of several
pathologies. The research lines involving EV cover a wide range of
aspects from basic research on the EV biology to the manipulation
or monitoring of EV for therapeutic purposes.
In this Research Topic, Andreu and Yáñez-Mó (1) discuss the
evidence for proteins of the tetraspanin family to be considered
as exosome markers and deliberate on their functions on exo-
somes, starting from biogenesis and cargo selection to the final
binding and fusion with the target cell. They also review the abil-
ity of exosomes of presenting antigen and the role of tetraspanins
in this process. Moreno-Gonzalo et al. (2) focus their review on
the suggestion that the incorporation of cargo into EV is a reg-
ulated process. They describe the post-translational modification
found in exosomal protein and their role in the complex mech-
anism of cargo sorting into the vesicles. In a perspective article,
Baixauli et al. (3) discuss about the function of exosomes as a
means to alleviate intracellular stress conditions, and how secre-
tion of harmful or unwanted material in exosomes, in coordination
with the autophagy-lysosomal pathway, is essential to preserve
intracellular protein and RNA homeostasis. They also give an
overview about the consequences of the spreading of exosomal
content in physiological and pathological situations and strate-
gies for therapeutic intervention. Compared with other secreted
vesicles, exosomes have much better defined biophysical and bio-
chemical properties. However, the isolation and characterization
protocols are not homogeneous in the published articles. Fran-
quesa et al. (4) contribute to this research topic with a methods
article in which they propose new controls for the detection and
quantification of EV derived from mesenchymal stem cells. These
three reviews and the method article provide an overview about
the most important basic concepts in the EV field.
Immunomodulatory potential is one of the main focuses of
study regarding EV that captures the attention of researchers work-
ing in several fields of medicine. Zhang et al. (5) review studies
which demonstrate the immense immunotherapeutic potential of
EV by effects on both immune and non-immune cells and also
highlight the divergent effects of EV on the immune system. They
argue that this divergence could be due to the cell source of EV
and other parameters such as the classes of EV and the methods of
isolation. Blázquez et al. (6) contribute to this topic with an orig-
inal article in which they describe in vitro experiments aimed at
characterizing the immunomodulatory effect of EV derived from
mesenchymal stem cells on stimulated T cells. The recent descrip-
tion of parasite EV in protozoan and helminths suggests that EV
can play an important role in host–parasite communication by
immunomodulation of the host immune response against the par-
asite. Montaner et al. (7) review current clinical trials about the
use of helminth secretory products to treat chronic inflammatory
and autoimmune diseases. Interestingly, some of the characterized
parasitic immunomodulatory proteins have been identified in EV,
and they discuss the intriguing possibility of the therapeutic use
of parasitic EV.
The therapeutic potential of EV is studied in different fields
such as organ transplantation, HIV, cardiovascular diseases (CVs),
tumor biology, and regenerative medicine. In this research topic,
nine reviews overview the role of EV in several pathologies. Two
reviews describe the role of EV derived from immune cells in the
transplantation field with different viewpoints. Agarwal et al. (8)
summarize the EV contribution to immune regulation and their
therapeutic potential in preventing graft rejection and Monguió-
Tortajada et al. (9) discuss the mechanisms involved in organ
tolerance mediated by the administration of EV. In the HIV field,
Soares (10) review the relevance of CD4 vesicles exocytosis to
immune regulation and to HIV-1 pathogenesis. CV continues to
be a leading cause of morbidity and mortality worldwide. EV are
considerably elevated in CV associated with inflammation and
have also been shown to have proangiogenic and cardioprotec-
tive properties. Fleury et al. (11) provide an update of cellular
processes modulated by EV of specific interest for the treatment
of cardiovascular pathologies with special focus on morphogen
sonic hedgehog (Shh). Because chronic kidney disease acts as a
risk multiplier in CV, Gonzalez-Calero et al. (12) analyze the role
of EV in the cardio-renal syndrome, in the search for novel key tar-
gets of interaction between heart and kidneys. Studies to the role
of EV in cancer are represented in this topic with two reviews and
one original research article. Julich et al. (13) discuss whether the
combination of EV profiling and miRNA profiling could be good
biomarkers for the detection of cancer and Bruno et al. (14) review
the role of EV derived from mesenchymal stem cells as therapeutic
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tools in tumor growth. On the other hand, the original results of
Di Noto et al. (15) open new insights in EV cellular biology and in
multiple myeloma therapeutic and diagnostic approaches.
In the area of regenerative medicine, EV can play a benefi-
cial role in restoring tissue and organ damage, and may partially
explain the paracrine effects observed in stem cell based therapeu-
tic approaches. De Jong et al. (16) discuss the function and role
of exosomes in regenerative medicine and elaborate on potential
applications in tissue engineering.
It is our hope that the advances highlighted here and the
questions raised for future consideration will generate additional
discussion, drive experimental inquiry, and bring the development
of EV as therapeutic tools into focus.
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